Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Apogee Therapeutics Inc.

    NASDAQ: APGE · Real-Time Price · USD
    42.68
    -1.80 (-4.05%)
    At close: Jun 16, 2025, 3:59 PM
    42.50
    -0.42%
    After-hours: Jun 16, 2025, 06:29 PM EDT

    Apogee Therapeutics Statistics

    Share Statistics

    Apogee Therapeutics has 59.53M shares outstanding. The number of shares has increased by 1.79% in one year.

    Shares Outstanding

    n/a
    		 59.53M

    Shares Change (YoY)

    n/a
    		 1.79%

    Shares Change (QoQ)

    n/a
    		 1.69%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 48.25M

    Failed to Deliver (FTD) Shares

    n/a
    		 814

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 10.15M, so 17.41% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.15M

    Short % of Shares Out

    n/a
    		 17.41%

    Short % of Float

    n/a
    		 37.07%

    Short Ratio (days to cover)

    n/a
    		 19.74

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -8.07

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 11

    PB Ratio

    n/a
    		 3.49

    P/FCF Ratio

    n/a
    		 -14.51

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Apogee Therapeutics has an Enterprise Value (EV) of 2.37B.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -10.93

    EV / EBIT

    n/a
    		 -13.85

    EV / FCF

    n/a
    		 -13.75

    Financial Position

    The company has a current ratio of 18.55, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 18.55

    Quick Ratio

    n/a
    		 18.55

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.07

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 0% and Return on Invested Capital is 0%.

    Return on Equity

    n/a
    		 0%

    Return on Assets

    n/a
    		 0%

    Return on Invested Capital

    n/a
    		 0%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 196

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -18K

    Effective Tax Rate

    n/a
    		 100%

    Stock Price Statistics

    The stock price has increased by 9.46% in the last 52 weeks. The beta is 1.39, so Apogee Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.39

    52-Week Price Change

    n/a
    		 9.46%

    50-Day Moving Average

    n/a
    		 37.34

    200-Day Moving Average

    n/a
    		 43.82

    Relative Strength Index (RSI)

    n/a
    		 59.77

    Average Volume (20 Days)

    n/a
    		 712,488

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -216.87M

    Net Income

    n/a
    		 n/a

    EBITDA

    n/a
    		 -216.87M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 141.79M in cash and 11.83M in debt, giving a net cash position of 129.96M.

    Cash & Cash Equivalents

    n/a
    		 141.79M

    Total Debt

    n/a
    		 11.83M

    Net Cash

    n/a
    		 129.96M

    Retained Earnings

    n/a
    		 -305.92M

    Total Assets

    n/a
    		 714.16M

    Working Capital

    n/a
    		 488.57M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -171.17M and capital expenditures -1.15M, giving a free cash flow of -172.33M.

    Operating Cash Flow

    n/a
    		 -171.17M

    Capital Expenditures

    n/a
    		 -1.15M

    Free Cash Flow

    n/a
    		 -172.33M

    FCF Per Share

    n/a
    		 -3.12
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    APGE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0%

    FCF Yield

    n/a
    		 -6.89%
    Dividend Details

    Analyst Forecast

    The average price target for APGE is $90, which is 110.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $90

    Price Target Difference

    n/a
    		 110.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 0

    Graham Upside

    n/a
    		 -100%

    Scores

    Altman Z-Score

    n/a
    		 30.86

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist